Introduction of Lamivudine for the Treatment of Chronic Hepatitis B: Expected Clinical and Economic Outcomes Based on 4-Year Clinical Trial Data

Journal of Gastroenterology and Hepatology - United Kingdom
doi 10.1046/j.1440-1746.2002.02673.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection: Rationale and Clinical Trial Evidence

Therapeutic Advances in Gastroenterology
Gastroenterology
2018English

Lamivudine for the Treatment of Membranous Glomerulopathy Secondary to Chronic Hepatitis B Infection

Canadian Journal of Gastroenterology
2005English

Lamivudine Treatment Can Restore T Cell Responsiveness in Chronic Hepatitis B.

Journal of Clinical Investigation
Medicine
1998English

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients With Elevated Hepatitis B Virus DNA Levels

PLoS ONE
Multidisciplinary
2015English

Association of Virological Breakthrough and Clinical Outcomes in Entecavir-Treated HBeAg-positive Chronic Hepatitis B

PLoS ONE
Multidisciplinary
2019English

Effect of Lamivudine Treatment on Survival of 309 North American Patients Awaiting Liver Transplantation for Chronic Hepatitis B

Liver Transplantation
HepatologyTransplantationSurgery
2002English

Associations of Chemokine System Polymorphisms With Clinical Outcomes and Treatment Responses of Chronic Hepatitis C

Gastroenterology
HepatologyGastroenterology
2003English

Pin38 - Clinical and Economic Impact of the Treatment of Chronic Hepatitis C in Prison Inmates in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C

Journal of Clinical and Translational Hepatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy